Henry Schein, Inc.  

(Public, NASDAQ:HSIC)   Watch this stock  
Find more results for HSIC
0.00 (0.00%)
Dec 18 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 109.34 - 138.41
Open     -
Vol / Avg. 0.00/555,449.00
Mkt cap 11.44B
P/E 25.59
Div/yield     -
EPS 5.31
Shares 84.21M
Beta 0.84
Inst. own 93%
Feb 9, 2015
Q4 2014 Henry Schein Inc Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Jan 13, 2015
Henry Schein Inc at JPMorgan Healthcare Conference - 4:30PM EST - Add to calendar
Dec 2, 2014
Henry Schein Inc at Piper Jaffray Healthcare Conference
Dec 2, 2014
Henry Schein Inc at NASDAQ OMX Investor Program - Webcast
Nov 19, 2014
Henry Schein Inc at Jefferies Global Healthcare Conference - London
Nov 18, 2014
Henry Schein Inc at Stifel Healthcare Conference
Nov 11, 2014
Henry Schein Inc at Credit Suisse Healthcare Conference
Nov 6, 2014
Q3 2014 Henry Schein Inc Earnings Call - Webcast
Nov 6, 2014
Q3 2014 Henry Schein Inc Earnings Release
Sep 30, 2014
Henry Schein Inc at Leerink Partners Services Roundtable - Webcast
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '14) 2013
Net profit margin 4.55% 4.96%
Operating margin 6.64% 7.08%
EBITD margin - 8.42%
Return on average assets 7.91% 8.65%
Return on average equity 16.24% 15.99%
Employees 16,000 -
CDP Score - -


135 Duryea Road
United States - Map
+1-631-8435500 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Henry Schein, Inc. is a provider of health care products and services to office-based practitioners. The Company conducts its business through two segments: healthcare distribution and technology. The healthcare distribution segment aggregates its dental, medical, animal health and international operating segments. This segment consists of consumable products, small equipment, laboratory products, large dental equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. In July 2014, the Company announced that its U.S. Animal Health business, Henry Schein Animal Health, has completed its acquisition of an approximate 60% ownership position in SmartPak.SmartPak provider of equine supplements and horse supplies across the United States.

Officers and directors

Stanley M. Bergman Chairman of the Board, Chief Executive Officer
Age: 64
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James P. Breslawski CPA President, Chief Operating Officer, Director; Chief Executive Officer of Henry Schein Global Dental Group
Age: 60
Bio & Compensation  - Reuters
Steven Paladino CPA Chief Financial Officer, Executive Vice President, Director
Age: 57
Bio & Compensation  - Reuters
David McKinley President, Medical Group
Age: 61
Bio & Compensation  - Reuters
Bob Minowitz President, International Dental Group
Age: 55
Bio & Compensation  - Reuters
Lonnie Shoff President and Chief Executive Officer of Global Animal Health and Strategic Partnerships Group
Age: 55
Bio & Compensation  - Reuters
Gerald A. Benjamin Chief Administrative Officer, Executive Vice President, Director
Age: 61
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Mark E. Mlotek Chief Strategic Officer, Executive Vice President, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
James A. Harding Chief Technology Officer, Senior Vice President
Age: 58
Bio & Compensation  - Reuters
Leonard A. David Chief Compliance Officer, Senior Vice President
Age: 65
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance